Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to existing treatment. The ...

An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

How can you make therapy work best for you? Here are a few tips. And a new study offers more evidence that teens are in trouble.

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

Netflix Inc. is raising prices again — though for some viewers, it’s actually been some time since the last hike. The company announced alongside its earnings Tuesday afternoon that it will be ...

Her expertise is in personal finance and investing, and real estate. Investopedia / Julie Bang The term cost of revenue refers to the total cost of manufacturing and delivering a product or ...

On Tuesday, the US Food and Drug Administration (FDA) approved Johnson & Johnson's hallucinogenic drug esketamine (brand name Spravato) nasal spray as a "monotherapy" treatment for major depressive ...

Unfortunately, it’s also often one of the most expensive. There are medical costs, as well as the necessities you’ll want to have on hand before you bring your little one home – not ...

If you're considering getting Starlink satellite internet, check out this simplified breakdown of the different pricing tiers, subscription costs, and equipment fees. My title is Senior Features ...

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.